Clinical Trial Update: Using MC1R Genotype to Impact Melanoma Risk Behavior [NA]

View source ↗

Summary

Completed clinical trial evaluating whether MC1R genotype information can influence melanoma risk-related behaviors. Results were posted in November 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Squamous Cell Carcinoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma (Skin), Squamous Cell Carcinoma | NA | Status: COMPLETED | Results posted: 2023-11-21